Gemcitabine Intravesical
INLEXZO
Nucleoside Metabolic Inhibitor
NADAC/unit
N/A
No Shortage
Gemcitabine Intravesical interferes with DNA synthesis to slow cancer cell or viral replication.
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.
